Gene expression correlation of immune checkpoint molecules Siglec-15 and PD-L1 varies widely by cancer indication

被引：0
|
作者：
Watkins, Krystal
Diao, Liyang
Crochiere, Marsha
Pinkas, Jan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1373
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1373
引用
收藏
页数：2
相关论文
共 50 条
  • [41] PD-1/PD-L1 immune checkpoint blockade in ovarian cancer: Dilemmas and opportunities
    Peng, Zikun
    Li, Ming
    Li, Huayi
    Gao, Qinglei
    DRUG DISCOVERY TODAY, 2023, 28 (08)
  • [42] Oral immune checkpoint antagonists targeting PD-L1/VISTA or PD-L1/Tim3 for cancer therapy
    Sasikumar, Pottayil
    Sudarshan, N. S.
    Gowda, Nagaraj
    Samiulla, D. S.
    Ramachandra, Raghuveer
    Chandrasekhar, T.
    Adurthi, Sreenivas
    Mani, Jiju
    Nair, Rashmi
    Singh, Sharad
    Dhudashia, Amit
    Gowda, Nagesh
    Ramachandra, Murali
    CANCER RESEARCH, 2016, 76
  • [43] Efficacy of PD-1/PD-L1 Immune Checkpoint Inhibitors for Advanced NSCLC According to PD-L1 Expression: A Meta-Analysis
    Ma, K.
    Guo, Y.
    Wang, Y.
    Wang, X.
    Xu, Y.
    Sun, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S584 - S584
  • [44] Quantifying PD-L1 Expression to Monitor Immune Checkpoint Therapy: Opportunities and Challenges
    Nimmagadda, Sridhar
    CANCERS, 2020, 12 (11) : 1 - 26
  • [45] A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors
    Chatterjee, Samit
    Lesniak, Wojciech G.
    Gabrielson, Matthew
    Lisok, Ala
    Wharram, Bryan
    Sysa-Shah, Polina
    Azad, Babak Behnam
    Pomper, Martin G.
    Nimmagadda, Sridhar
    ONCOTARGET, 2016, 7 (09) : 10215 - 10227
  • [46] Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers
    Duruisseaux, Michael
    Rouquette, Isabelle
    Adam, Julien
    Cortot, Alexis
    Cazes, Aurelie
    Gibault, Laure
    Damotte, Diane
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 61 - 78
  • [47] Progress in understanding the regulatory mechanisms of immune checkpoint proteins PD-1 and PD-L1 expression
    Wu, Xuanxuan
    Zhu, Zengjun
    Zhang, Jian
    Tian, Maojin
    Zhao, Peiqing
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
  • [48] Regulation of Pulmonary Fibrosis by Immune Checkpoint PD-L1
    Geng, Y.
    Liang, C. J.
    Habiel, D. M.
    Coelho, A.
    Xie, T.
    Vrishika, K.
    Liu, N.
    Hogaboam, C. M.
    Jiang, D.
    Noble, P. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [49] Isothiocyanates attenuate immune checkpoint blockage therapy in gastric cancer via induction of PD-L1 expression
    Zhang, Qi
    Cao, Wanshuang
    Yang, Chenying
    Hong, Lixia
    Geng, Shanshan
    Han, Hongyu
    Zhong, Caiyun
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2023, 112
  • [50] PD-L1 and PD-L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules
    Zhang, Yue
    Chen, Xianlong
    Mo, Shengwei
    Ma, Heng
    Lu, Zhaohui
    Yu, Shuangni
    Chen, Jie
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2022, 8 (03): : 257 - 267
12345